All posts by : Zoja

Pikralida announces successful completion of Scientific Advice discussion with the Finnish Medicines Agency Fimea for PKL-021. Agreement on Phase 1 clinical trial design.Poznan, Poland, March 27, 2023 – Pikralida sp. z o.o., biopharmaceutical compan ...

On 15 and 16 November, we will participate in the Deep Tech Summit, which will be held in the Cambridge Innovation Center in Warsaw.The intention behind the event is to connect and educate:private investors seeking unique projects,start-up founders ...

We are very proud to announce that Pikralida has been included in the Deeptech Map in the Central European region. Technologies dubbed “deep tech” are defined as breakthrough solutions based on technological achievements that are unique, protected and di ...

Our Scientists: Hanna Kierońska, Katarzyna Rogut and Michał Kretkiewicz took part in the international scientific conference 'New trends in Polish and global pharmacy: science, business and modern education', held in Poznań on 29-30 September 2022.I ...

Joanna Lipner represented Pikralida at THURSDAY GATHERING, taking part in the debate and presenting the company during the pitching session.The topic of the debate, chaired by Izabela Kozakiewicz-Frańczak, was: “Industries of tomorrow: Medicine”. ...

Pikralida sp. z o.o. is one of the winners of the “Rzeczpospolita” Innovation Eagle awards in the category Start-up with potential Poland – GlobalOur start-up received an award for work dedicated to the discovery and development of small-molecule ch ...

An innovative project implemented by Pikralida: “Use of matrix metalloproteinase inhibitor for the development of an innovative therapeutic method for preventing the development of post-injury and post-stroke epilepsy” has been included in the healthcare ...

Joanna Lipner represented Pikralida sp. zo.o. in a panel discussion at Big Pharma Day2022, an event organised this year by the CITTRU Technology Transfer Centre at the Jagiellonian University.Knowledge exchange and experience sharing is crucial t ...

Anna Krause and Stanisław Pikul represented Pikralida at the 7th Scientific and Training Conference of the Polish Neurological Society held on 14-17 September in Lublin.A poster presenting the results of the in vivo research conducted as part of the Ep ...

Pikralida has been invited to have its say in Science|Busines magazine on the topic of the challenges and issues faced in Poland by companies dealing in innovative drug development.Polish biotechnology is seeking a solid foundation for future growth Ge ...